| Title | Author(s) | Issue date | ???itemlist.??? |
| Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1 | Karavasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Kalofonos, H.; Fountzilas, G.; Fotsis, T.; Pavlidis, N. | 24-Nov-2015 | - |
| Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study | Briasoulis, E.; Kalofonos, H.; Bafaloukos, D.; Samantas, E.; Fountzilas, G.; Xiros, N.; Skarlos, D.; Christodoulou, C.; Kosmidis, P.; Pavlidis, N. | 24-Nov-2015 | - |
| Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer | Samantas, E.; Skarlos, D. V.; Pectasides, D.; Nicolaides, P.; Kalofonos, H.; Mylonakis, N.; Vardoulakis, T.; Kosmidis, P.; Pavlidis, N.; Fountzilas, G. | 24-Nov-2015 | - |
| Correlation of mammographic appearance and molecular prognostic factors in high-grade breast carcinomas | Likaki-Karatza, E.; Ravazoula, P.; Androutsopoulos, G. P.; Michail, G.; Batistatou, A.; Tzorakoleftherakis, E.; Kalofonos, H.; Kourounis, G. | 24-Nov-2015 | - |
| Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: a Hellenic Cooperative Oncology Group Phase II study | Fountzilas, G.; Nicolaides, C.; Bafaloukos, D.; Kalogera-Fountzila, A.; Kalofonos, H.; Samelis, G.; Aravantinos, G.; Pavlidis, N. | 24-Nov-2015 | - |
| Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer | Fountzilas, G.; Papadimitriou, C.; Aravantinos, G.; Nicolaides, C.; Stathopoulos, G.; Bafaloukos, D.; Kalofonos, H.; Ekonomopoulos, T.; Skarlos, D.; Pavlidis, N.; Dimopoulos, A. M. | 24-Nov-2015 | - |
| Dose-dense sequential chemotherapy with epirubicin and paclitaxel in advanced breast cancer | Razis, E.; Dimopoulos, A. M.; Bafaloukos, D.; Papadimitriou, C.; Kalogera-Fountzila, A.; Kalofonos, H.; Briassoulis, E.; Samantas, E.; Keramopoulos, A.; Pavlidis, N.; Kosmidis, P.; Fountzilas, G. | 24-Nov-2015 | - |
| Matrix metalloproteinases in carcinoma of unknown primary | Karavasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kitsou, E.; Kalofonos, H.; Fountzilas, G.; Fotsis, T.; Pavlidis, N. | 24-Nov-2015 | - |
| Metronomic Oral Vinorelbine in Patients with Recurrent Breast, Prostate or Non-Small Cell Lung Cancer: Optimal Dose-Finding Trial of the Hellenic Cooperative Oncology Group | Briasoulis, E.; Kalofonos, H.; Samantas, E.; Varthalitis, I.; Syrigos, K. N.; Fountzilas, G.; Pappas, P.; Sainis, I.; Puozzo, C.; Pavlidis, N. | 24-Nov-2015 | - |
| Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study | Briasoulis, E.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Xiros, N.; Aravantinos, G.; Samantas, E.; Kalofonos, H.; Makatsoris, T.; Mylonakis, N.; Papakostas, P.; Skarlos, D.; Varthalitis, I.; Pavlidis, N. | 24-Nov-2015 | - |
| Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Stathopoulos, G.; Nicolaides, C.; Kalogera-Fountzila, A.; Kalofonos, H.; Nikolaou, A.; Bacoyiannis, C.; Samantas, E.; Papadimitriou, C.; Kosmidis, P.; Daniilidis, J.; Pavlidis, N. | 24-Nov-2015 | - |
| Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology Group | Fountzilas, G.; Papakostas, P.; Dafni, U.; Makatsoris, T.; Karina, M.; Kalogera-Fountzila, A.; Maniadakis, N.; Aravantinos, G.; Syrigos, K.; Bamias, A.; Christodoulou, C.; Economopoulos, T.; Kalofonos, H.; Nikolaou, A.; Angouridakis, N.; Stathopoulos, G.; Bafaloukos, D.; Pavlidis, N.; Daniilidis, J. | 24-Nov-2015 | - |
| Phase I study of etoposide, cisplatin and irinotecan triplet in patients with advanced-stage small-cell lung cancer | Briasoulis, E.; Samantas, E.; Kalofonos, H.; Skarlos, D.; Makatsoris, T.; Christodoulou, C.; Fountzilas, G.; Bamias, A.; Dimopoulos, M. A.; Kosmidis, P.; Pavlidis, N. | 24-Nov-2015 | - |
| Proteolysis and angiogenesis in cancer of unknown primary. A clinicopathological study | Karavasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; Tsanou, E.; Kalofonos, H.; Fountzilas, G.; Kitsou, E.; Fotsis, T.; Pavlidis, N. | 24-Nov-2015 | - |
| A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study | Fountzilas, G.; Athanassiades, A.; Giannakakis, T.; Briasoulis, E.; Bafaloukos, D.; Kalogera-Fountzila, A.; Onienaoum, A.; Kalofonos, H.; Pectasides, D.; Andreopoulou, E.; Bamia, C.; Kosmidis, P.; Pavlidis, N.; Skarlos, D. | 24-Nov-2015 | - |
| Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival | Kostadima, L.; Pentheroudakis, G.; Fountzilas, G.; Dimopoulos, M.; Pectasides, D.; Gogas, H.; Stropp, U.; Christodoulou, C.; Samantas, E.; Wirtz, R.; Hennig, G.; Bafaloukos, D.; Arapantoni, P.; Kalofonos, H.; Papakostas, P.; Economopoulos, T.; Bamias, A.; Pavlidis, N. | 24-Nov-2015 | - |
